lunes, 17 de diciembre de 2012

Genes predict if trastuzumab will work for breast cancer patients - National Cancer Institute

Genes predict if trastuzumab will work for breast cancer patients - National Cancer Institute




NCI Cancer Center News


Genes predict if trastuzumab will work for breast cancer patients



Posted: 12/10/2012






Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. A team of U.S. researchers, led by oncologists at Mayo Clinic's campus in Florida, have discovered 27 genes that are significantly associated with a good outcome with concurrent use of trastuzumab and chemotherapy, as well as five other genes linked to a poor outcome using the same treatment regimen.
Click here to read full press release Exit Disclaimer.

No hay comentarios:

Publicar un comentario